Nitzan Rosenfeld receives Translational Research Award
Congratulations to Nitzan Rosenfeld, who has won the 2013 British Association for Cancer Research Translational Research Award.
The purpose of the award is to recognise and reward the achievements of an individual whose work has made significant contributions to translational (laboratory – clinic) cancer research.
The lab are working on developing effective methods to make use of circulating tumour DNA (ctDNA), which is found in blood and other body fluids and contains much useful information about a patient’s cancer. For example, by using genomic techniques to study ctDNA researchers can learn about the evolution of a patient’s tumour and how it is developing resistance to therapy. The advantage of using ctDNA to diagnose and monitor disease is that it can be collected relatively non-invasively, through a blood test rather than a tumour biopsy, and ease of sample collection means that you can take many more samples to follow the development and changes in a tumour.
Related News
See all news-
Dr Magdalena Crossley awarded £2 million Wellcome Career Development Award
11th September 2026
Dr Magdalena Crossley has been awarded a £2 million Wellcome Career Development Award to investigate how unusual RNA-DNA structures contribute to cancer and other diseases.
Find out more -
Study reveals how our inherited genes interact with DNA damage to drive cancer
27th July 2026
Find out more -
Dr Guiping Wang appointed as a Junior Group Leader
18th May 2026
Dr Guiping Wang joins the Cancer Research UK Cambridge Institute as a Junior Group Leader, starting in September 2026.
Find out more